Firstly, they compared eryptosis levels and systemic inflammatory markers (such as CRP, IL-6, and IL-1β) in 31 PD patients with acute peritonitis and 34 PD patients with no history of systemic inflammation or peritonitis in the past three months, representing the control group. This evidence concerns the gene IL1B and peritonitis.